Status:
RECRUITING
Rare Glycogen Storage Diseases Natural History Study
Lead Sponsor:
Duke University
Conditions:
Glycogen Storage Disease
GSD Type 0A
Eligibility:
All Genders
0-90 years
Brief Summary
The purpose of this study is to collect and study key medical data about several ultra-rare GSDs (Glycogen Storage Diseases) including, but not limited to, GSD types 0a, 0b, VII, X, XII, XIII, XV, PRK...
Detailed Description
The immediate goal of this research is to create a natural history database to collect information from individuals who have a rare GSD. A repository of clinical, laboratory, and biochemical informati...
Eligibility Criteria
Inclusion Criteria:
-
Diagnosis of a rare GSD, including 0a, 0b, VII, X, XII, XIII, XV, PRKAG2 syndrome or Danon disease
- Two variants in the gene associated with the specific GSD type (for autosomal recessive diseases)
- One variant in the gene associated with the specific GSD type (for autosomal dominant or X-linked diseases)
- Deficient enzyme activity in liver, muscle, skin fibroblast or other tissue
- One variant in causative gene with evidence of disease, per a clinician
- Histology as confirmed by a clinician
-
Able to provide informed consent for self (adults) or affected individual (minor or adults with a legally authorized representative)
-
Able to provide consent for release of medical records
-
Pregnant women with a diagnosis of a rare GSD will be included
Exclusion Criteria:
- Unable to provide informed consent for participation for one's self or by legally authorized representative/legal guardian/parent
Key Trial Info
Start Date :
December 23 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2034
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06795152
Start Date
December 23 2024
End Date
December 1 2034
Last Update
January 7 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke University
Durham, North Carolina, United States, 27710